{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:58:06Z","timestamp":1781200686830,"version":"3.54.1"},"reference-count":30,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabet Med"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Early detection of type 2 diabetes (T2D) and prediabetes is critical to reduce disease burden, yet disadvantaged populations often remain undiagnosed. We assessed a pharmacy\u2010based pathway using verified point\u2010of\u2010care HbA1c testing to identify prediabetes and enable engagement with a digital prevention programme and established the detection rates for undiagnosed T2D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a prospective feasibility study across 16 community pharmacies in NHS Tayside, Scotland (Feb 2024\u2013Jan 2025). Adults at high risk of T2D, identified using the Diabetes UK \u2018\n                      <jats:italic>Know Your Risk<\/jats:italic>\n                      \u2019 tool, were offered HbA1c testing. Participants with HbA1c 42\u201347\u2009mmol\/mol (6.0\u20136.4%) were referred directly to a digital diabetes prevention programme (DDP); those with HbA1c \u226548\u2009mmol\/mol (6.5%) were advised to attend their GP. Comparator data were drawn from GP patients identified for engagement with the same DPP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 499 pharmacy participants, 75 (15%) had prediabetes; 38 (51%) enrolled in DPP. Nineteen (4%) had HbA1c \u226548\u2009mmol\/mol (6.5%); 17 attended GP. Compared with GP\u2010identified prediabetes (951 patients; 212 enrolled, 32%), pharmacy\u2010based recruitment doubled DDP engagement (RR 2.08, 95% CI 1.61\u20132.67). Pharmacy recruited relatively younger participants from more deprived backgrounds (63% SIMD 1\u20132 vs. 33% in GP cohort).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Community pharmacies provided effective, equitable access to HbA1c testing and diabetes prevention, identifying individuals with prediabetes and undiagnosed T2D being missed by current pathways and doubling engagement of this underserved population with DPP. Pharmacy\u2010based screening offers a scalable opportunity to reduce health inequalities and expand primary care capacity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dme.70368","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:01:01Z","timestamp":1778907661000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detection of prediabetes and undiagnosed type 2 diabetes in underserved communities using community pharmacy point\u2010of\u2010care testing: A prospective feasibility study"],"prefix":"10.1111","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4772-2388","authenticated-orcid":false,"given":"Andrew","family":"Radley","sequence":"first","affiliation":[{"name":"Faculty of Health University of Dundee, Airlie Place  Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Beer","sequence":"additional","affiliation":[{"name":"Tayside Clinical Trials Unit, Ninewells Hospital and Medical School University of Dundee  Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8970-6146","authenticated-orcid":false,"given":"Albert","family":"Farre","sequence":"additional","affiliation":[{"name":"Faculty of Health University of Dundee, Airlie Place  Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Rauchhaus","sequence":"additional","affiliation":[{"name":"Tayside Clinical Trials Unit, Ninewells Hospital and Medical School University of Dundee  Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Thom","sequence":"additional","affiliation":[{"name":"Public Health Directorate NHS Tayside, Ninewells Hospital and Medical School  Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calum","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Faculty of Health University of Dundee, Airlie Place  Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"e_1_2_13_2_1","volume-title":"Global Report on Diabetes","author":"World Health Organization","year":"2016"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.11.001"},{"key":"e_1_2_13_4_1","unstructured":"Scottish Diabetes Data Group.Scottish Diabetes Survey 2018.NHS Scotland;2019.https:\/\/www.diabetesinscotland.org.uk"},{"key":"e_1_2_13_5_1","unstructured":"Scottish Public Health Observatory.Diabetes: Mortality data. Accessed December 2025.https:\/\/www.scotpho.org.uk\/health\u2010conditions\/diabetes\/data\/mortality\/"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1425"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-7-249"},{"key":"e_1_2_13_8_1","volume-title":"A Healthier Future: Type 2 Diabetes Prevention, Early Detection and Intervention Framework","author":"Scottish Government","year":"2018"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30068-3"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2014.12.019"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58033-3"},{"key":"e_1_2_13_12_1","unstructured":"Diabetes UK.Diabetes\u2014Know your risk. Accessed December 2025.https:\/\/riskscore.diabetes.org.uk\/start"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-007328"},{"key":"e_1_2_13_14_1","volume-title":"Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia","author":"World Health Organization","year":"2006"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.10.1563"},{"key":"e_1_2_13_16_1","volume-title":"Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus","author":"World Health Organization","year":"2011"},{"key":"e_1_2_13_17_1","unstructured":"SchaffertL\u2010N EnglishE HeneghanC et\u00a0al.Point\u2010of\u2010care HbA1c tests\u2014diagnosis of diabetes. NIHR Horizon Scan Report2016."},{"issue":"1","key":"e_1_2_13_18_1","first-page":"7","article-title":"Implementation of point\u2010of\u2010care HbA1c instruments into community pharmacies: initial development of a pathway for robust community testing","volume":"61","author":"Radley A","year":"2024","journal-title":"Ann Clin Biochem"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2023.10.011"},{"key":"e_1_2_13_20_1","unstructured":"Public Health Scotland.General Practice List Sizes and Demographics Information. Accessed December 2025.https:\/\/publichealthscotland.scot\/publications\/general\u2010practice\u2010list\u2010size\u2010and\u2010demographics\u2010information"},{"key":"e_1_2_13_21_1","unstructured":"Abbott.Afinion HbA1c Dx. Accessed December 2025.https:\/\/www.globalpointofcare.abbott\/en\/product\u2010details\/afinion\u2010hba1c\u2010dx.html"},{"key":"e_1_2_13_22_1","unstructured":"Second Nature.Digital Diabetes Prevention Programme. Accessed December 2025.https:\/\/www.secondnature.io"},{"key":"e_1_2_13_23_1","unstructured":"SCI\u2010Diabetes.Scottish Care Information Diabetes. Accessed December 2025.https:\/\/www.sci\u2010diabetes.scot.nhs.uk"},{"key":"e_1_2_13_24_1","unstructured":"Scottish Index of Multiple Deprivation. Accessed December 2025.https:\/\/simd.scot\/"},{"key":"e_1_2_13_25_1","unstructured":"Public Health Scotland.NHS Pharmacy First Scotland and Community Pharmacy Unscheduled Supply. Accessed December 2025.https:\/\/publichealthscotland.scot\/media\/29335\/2024\u201010\u201008\u2010nhs\u2010pharmacy\u2010first\u2010and\u2010unscheduled\u2010supply\u2010summary\u2010final.pdf"},{"key":"e_1_2_13_26_1","unstructured":"Office for National Statistics (ONS).ONS website statistical bulletin Risk factors for pre\u2010diabetes and undiagnosed type 2 diabetes in England: 2013 to 2019.2024."},{"key":"e_1_2_13_27_1","volume-title":"Heart Disease: Action Plan","author":"Scottish Government","year":"2021"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15529"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riaf005"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110566"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-025-01605-2"}],"container-title":["Diabetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dme.70368","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dme.70368","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dme.70368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:19:32Z","timestamp":1781198372000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dme.70368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1111\/dme.70368"],"URL":"https:\/\/doi.org\/10.1111\/dme.70368","archive":["Portico"],"relation":{},"ISSN":["0742-3071","1464-5491"],"issn-type":[{"value":"0742-3071","type":"print"},{"value":"1464-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2026-02-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70368"}}